Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

176.05
Delayed Data
As of Jan 12
 -1.07 / -0.60%
Today’s Change
160.07
Today|||52-Week Range
256.80
+7.62%
Year-to-Date

Today’s Trading

Previous close177.12
Today’s open177.62
Day’s range175.79 - 180.56
Volume2,802,192
Average volume (3 months)3,461,898
Market cap$58.6B
Data as of 4:01pm ET, 01/12/2018

Growth & Valuation

Earnings growth (last year)+281.42%
Earnings growth (this year)+20.20%
Earnings growth (next 5 years)+7.35%
Revenue growth (last year)-3.32%
P/E ratioNM
Price/Sales5.55
Price/Book0.83

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca-0.13-0.36%
ABTAbbott Laboratories-0.11-0.19%
LLYEli Lilly and Co+0.59+0.68%
NVONovo Nordisk+0.08+0.15%
Data as of 9:03am ET, 01/16/2018

Financials

Next reporting dateFebruary 21, 2018
EPS forecast (this quarter)$4.73
Annual revenue (last year)$14.6B
Annual profit (last year)$15.0B
Net profit margin-6.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chairman, President &
Chief Executive Officer
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts